13F
← All fund report cards

IMA Advisory Services, Inc.

13F equity value
$1.0B
Positions
1,033
Top 10 concentration
43.1%
Quarters / total new picks
32 / 1,232
13F equity value over time
$0M$521M$1B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = 1.38, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+2.0%
t-stat
1.38
Quarterly win rate
47%
Annualized excess
+2.2%
$1 → follow vs universe
$2.45 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.13320180630: follow 1.06920180930: follow 1.10720181231: follow 1.04520190331: follow 1.00920190630: follow 1.10720190930: follow 1.27120191231: follow 0.93720200331: follow 1.12120200630: follow 1.20120200930: follow 1.33920201231: follow 1.36120210331: follow 1.32420210630: follow 1.47920210930: follow 1.55220211231: follow 1.26920220331: follow 1.44320220630: follow 1.28320220930: follow 1.34520221231: follow 1.27720230331: follow 1.41920230630: follow 1.43520230930: follow 2.16820231231: follow 2.37520240331: follow 2.54920240630: follow 2.72520240930: follow 2.81820241231: follow 2.26020250331: follow 2.37820250630: follow 2.47320250930: follow 2.40020251231: follow 2.448 0.84 1.94 3.04 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1033 · 2026 Q1

Ticker Value Weight QoQ
VV $79M
7.7%
HOLD
SUSA $69M
6.7%
HOLD
DMXF $56M
5.4%
HOLD
DSI $50M
4.9%
HOLD
SCHX $47M
4.6%
ADD
VSGX $34M
3.4%
TRIM
ESGV $31M
3.0%
HOLD
JCPB $27M
2.7%
ADD
VXUS $24M
2.4%
TRIM
BSCU $24M
2.4%
ADD
BSCT $23M
2.3%
ADD
SCHB $21M
2.1%
TRIM
SPY $19M
1.8%
HOLD
BND $18M
1.8%
ADD
SCZ $18M
1.7%
ADD
SCHM $15M
1.4%
HOLD
SCHA $14M
1.4%
ADD
HYDB $14M
1.3%
HOLD
VSS $13M
1.3%
HOLD
NVDA $12M
1.1%
HOLD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.